The CM-Path initiative is holding the second symposium in this series. The aim of the CM-Path Biomarker Symposium Series is to inspire and enthuse pathologists and others with academic research by showcasing emerging techniques and advances in cancer research relevant to pathology. This workshop will cover the emerging technique of liquid biopsy, including the detection of circulating tumour cells and DNA with the following discussion points:

  • Circulating tumour cell and ctDNA - where are we now?
  • Recent advances in technology - where are we going?
  • Applications in research & clinical trials.
  • Benefits and barriers to widespread adoption in clinical practice.
Held at the Max Rayne Auditorium, Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE